The FDA issued a report that describes the South Korean government's response to COVID-19 and its success in "flattening the curve."

If your email program has trouble displaying this email, view as a webpage. South Korea's Response to COVID-19 Today the Food and Drug Administration (FDA) issued a report that describes some of the approaches used by the South Korean government to address COVID-19, particularly regarding development, authorization, and use of diagnostic tests. Numerous sources around the world declared South Korea's response strategy had successfully "flattened the curve" of COVID-19. As South Korea's experience may be informative for future considerations, the FDA reviewed information, including reports in the press and information made publicly available by the South Korean government about their COVID-19 response strategy. Read the Report Questions? If you have questions about this report, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA